T1	Pharmacological_substance 10 21	Vincristine
N1000 	Reference T1 MeSH:D014750	Vincristine
T2	Disorder 30 52	cranial polyneuropathy
N1 	Reference T2 UMLS:C0152025	cranial polyneuropathy
T3	Pharmacological_substance 104 115	vincristine
N1001 	Reference T3 MeSH:D014750	vincristine
T4	Disorder 124 146	cranial polyneuropathy
N2 	Reference T4 UMLS:C0152025	cranial polyneuropathy
T5	Pharmacological_substance 152 162	pyridoxine
N1002 	Reference T5 MeSH:D011736	pyridoxine
T6	Pharmacological_substance 167 181	pyridostigmine
N1003 	Reference T6 MeSH:D011729	pyridostigmine
T7	Disorder 225 263	preB cell Acute Lymphoblastic Leukemia
T8	Disorder 265 268	ALL
N3 	Reference T8 UMLS:C0023449	ALL
T9	Pharmacological_substance 416 427	vincristine
N1004 	Reference T9 MeSH:D014750	vincristine
T11	Pharmacological_substance 742 752	pyridoxine
N1005 	Reference T11 MeSH:D011736	pyridoxine
T12	Pharmacological_substance 757 771	pyridostigmine
N1006 	Reference T12 MeSH:D011729	pyridostigmine
T13	Pharmacological_substance 842 852	pyridoxine
N1007 	Reference T13 MeSH:D011736	pyridoxine
T14	Pharmacological_substance 857 871	pyridostigmine
N1008 	Reference T14 MeSH:D011729	pyridostigmine
T10	Disorder 448 464	bilateral ptosis
N4 	Reference T10 UMLS:C0033377	bilateral ptosis
N5 	Reference T10 UMLS:C0005745	bilateral ptosis
T19	Subject 69 84	5-year-old girl
T22	Disorder 500 516	bilateral ptosis
N6 	Reference T22 UMLS:C0033377	bilateral ptosis
N7 	Reference T22 UMLS:C0005745	bilateral ptosis
T23	Disorder 522 554	complete external opthalmoplegia
T24	Subject 195 210	5-year-old girl
T25	Disorder 1088 1094	ptosis
N8 	Reference T25 UMLS:C0033377	ptosis
N9 	Reference T25 UMLS:C0005745	ptosis
T26	Disorder 791 807	bilateral ptosis
N10 	Reference T26 UMLS:C0033377	bilateral ptosis
N11 	Reference T26 UMLS:C0005745	bilateral ptosis
T27	Disorder 671 677	ptosis
N12 	Reference T27 UMLS:C0033377	ptosis
N13 	Reference T27 UMLS:C0005745	ptosis
T28	Pharmacological_substance 638 648	vincristin
N1009 	Reference T28 MeSH:D014750	vincristin
T30	Manner_cue 808 816	markedly
T31	Coreferring_mention 927 938	both agents
T32	Coreferring_mention 271 274	She
T34	Pharmacological_substance 284 296	chemotherapy
N1010 	Reference T34 MeSH:C403362	chemotherapy
N1011 	Reference T34 MeSH:D004113	chemotherapy
N1012 	Reference T34 MeSH:C057647	chemotherapy
T35	Coreferring_mention 599 602	She
T39	Coreferring_mention 429 432	she
T42	Negation_cue 986 993	without
T18	Combination 853 856	and
T17	Combination 719 728	treatment
T38	Combination 163 166	and
